tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ORIC Stock Latest News

ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
Press ReleasesORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer
8d ago
ORIC
Oric announces clinical collaborations with Bayer, Janssen
PremiumThe Fly
Oric announces clinical collaborations with Bayer, Janssen
8d ago
JNJ
ORIC
Oric rally spurred by Pfizer trial update, says Oppenheimer
PremiumThe Fly
Oric rally spurred by Pfizer trial update, says Oppenheimer
14d ago
PFE
ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19d ago
ORIC
Oric Pharmaceuticals participates in a conference call with JPMorgan
PremiumThe Fly
Oric Pharmaceuticals participates in a conference call with JPMorgan
1M ago
ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2M ago
ORIC
Oric Pharmaceuticals price target lowered to $14 from $15 at Citi
PremiumThe Fly
Oric Pharmaceuticals price target lowered to $14 from $15 at Citi
3M ago
ORIC
Oric Pharmaceuticals reports Q1 EPS (37c), consensus (44c)
PremiumThe Fly
Oric Pharmaceuticals reports Q1 EPS (37c), consensus (44c)
3M ago
ORIC
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
PremiumPress Releases
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates
3M ago
ORIC
ORIC Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ORIC Earnings this Week: How Will it Perform?
3M ago
ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3M ago
ORIC
Oric Pharmaceuticals participates in a conference call with JPMorgan
PremiumThe Fly
Oric Pharmaceuticals participates in a conference call with JPMorgan
3M ago
ORIC
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
PremiumPress ReleasesORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
3M ago
ORIC
Oric doses first patient in dose escalation portion of ORIC-114 trial
PremiumThe Fly
Oric doses first patient in dose escalation portion of ORIC-114 trial
3M ago
ORIC
Oric Pharmaceuticals presents preclinical data on ORIC-944, ORIC-613
PremiumThe Fly
Oric Pharmaceuticals presents preclinical data on ORIC-944, ORIC-613
4M ago
ORIC
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
4M ago
ORIC
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
PremiumPress Releases
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
4M ago
ORIC
Oric Pharmaceuticals Bolsters Incentive Plan to Attract Talent
PremiumCompany Announcements
Oric Pharmaceuticals Bolsters Incentive Plan to Attract Talent
4M ago
8K
ORIC
Oric Pharmaceuticals price target lowered to $18 from $19 at JPMorgan
PremiumThe Fly
Oric Pharmaceuticals price target lowered to $18 from $19 at JPMorgan
4M ago
ORIC
Oric Pharmaceuticals price target raised to $21 from $15 at H.C. Wainwright
PremiumThe FlyOric Pharmaceuticals price target raised to $21 from $15 at H.C. Wainwright
4M ago
ORIC
Oric Pharmaceuticals price target raised to $17 from $14 at Oppenheimer
PremiumThe Fly
Oric Pharmaceuticals price target raised to $17 from $14 at Oppenheimer
4M ago
PFE
ORIC
Oric Pharmaceuticals price target lowered to $25 from $27 at Baird
PremiumThe Fly
Oric Pharmaceuticals price target lowered to $25 from $27 at Baird
4M ago
ORIC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >